The prevalence of epigenetic mechanisms in the regulation of cognitive functions and behaviour

Current Opinion in Neurobiology

Volumn 20, Issue 4, 2010, Pages 441-449

  Franklin, Tamara B ^a   Mansuy, Isabelle M ^a  

^a University of Zurich Brain Research Institute   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; FRAGILE X MENTAL RETARDATION PROTEIN; GLUTAMATE DECARBOXYLASE 67; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HUNTINGTIN; IMIPRAMINE; METHYL CPG BINDING PROTEIN 2; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; PRESENILIN 1; REELIN; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT;

ACETYLATION; ALZHEIMER DISEASE; AUTISM; BEHAVIOR DISORDER; CHROMOSOME DUPLICATION; COGNITIVE DEFECT; CONDITIONING; DEPRESSION; DNA METHYLATION; DRUG DEPENDENCE; ELECTROCONVULSIVE THERAPY; EPIGENETICS; FEAR; FRAGILE X SYNDROME; GENE EXPRESSION; GENE MUTATION; GENOME IMPRINTING; HAPPY PUPPET SYNDROME; HUMAN; HUNTINGTON CHOREA; LONG TERM MEMORY; MEMORY DISORDER; NONHUMAN; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REINFORCEMENT; RETT SYNDROME; REVIEW; RUBINSTEIN SYNDROME; SCHIZOPHRENIA; TRANSCRIPTION REGULATION; TRINUCLEOTIDE REPEAT; X CHROMOSOME INACTIVATION;

ANIMALS; BEHAVIOR; BEHAVIORAL SYMPTOMS; BRAIN DISEASES; COGNITION; COGNITION DISORDERS; DNA METHYLATION; EPIGENESIS, GENETIC; HISTONES; HUMANS; LEARNING; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRINUCLEOTIDE REPEATS;

EID: 77956651718     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.conb.2010.04.007     Document Type: Review

References (75)

1. Mager J., Bartolomei M.S. Strategies for dissecting epigenetic mechanisms in the mouse. Nat Genet 2005, 37:1194-1200.
2. Tweedie-Cullen R.Y., Reck J.M., Mansuy I.M. Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J Proteome Res 2009, 8:4966-4982.
3. Nathan D., Ingvarsdottir K., Sterner D.E., Bylebyl G.R., Dokmanovic M., Dorsey J.A., Whelan K.A., Krsmanovic M., Lane W.S., Meluh P.B., et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev 2006, 20:966-976.
4. Nelson C.J., Santos-Rosa H., Kouzarides T. Proline isomerization of histone H3 regulates lysine methylation and gene expression. Cell 2006, 126:905-916.
5. Healy S., Perez-Cadahia B., Jia D., McDonald M.K., Davie J.R., Gravel R.A. Biotin is not a natural histone modification. Biochim Biophys Acta 2009, 1789:719-733.
6. Jiang T., Zhou X., Taghizadeh K., Dong M., Dedon P.C. N-Formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage. Proc Natl Acad Sci U S A 2007, 104:60-65.
7. Suganuma T., Workman J.L. Crosstalk among histone modifications. Cell 2008, 135:604-607.
8. Zippo A., Serafini R., Rocchigiani M., Pennacchini S., Krepelova A., Oliviero S. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 2009, 138:1122-1136.
9. Lee M.G., Villa R., Trojer P., Norman J., Yan K.P., Reinberg D., Di Croce L., Shiekhattar R. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 2007, 318:447-450.
10. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005, 15:490-495.
11. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009, 10:295-304.
12. Lehnertz B., Ueda Y., Derijck A.A., Braunschweig U., Perez-Burgos L., Kubicek S., Chen T., Li E., Jenuwein T., Peters A.H. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003, 13:1192-1200.
13. Cervoni N., Szyf M. Demethylase activity is directed by histone acetylation. J Biol Chem 2001, 276:40778-40787.
14. Jones P.L., Veenstra G.J., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Strouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 1998, 19:187-191.
15. Robertson K.D. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610.
16. Mehler M.F. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol 2008, 86:305-341.
17. Kangaspeska S., Stride B., Metivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., Benes V., Gannon F., Reid G. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115.
18. Metivier R., Gallais R., Tiffoche C., Le Peron C., Jurkowska R.Z., Carmouche R.P., Ibberson D., Barath P., Demay F., Reid G., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
19. Levenson J.M., O'Riordan K.J., Brown K.D., Trinh M.A., Molfese D.L., Sweatt J.D. Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem 2004, 279:40545-40559.
20. Korzus E., Rosenfeld M.G., Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron 2004, 42:961-972.
21. Alarcon J.M., Malleret G., Touzani K., Vronskaya S., Ishii S., Kandel E.R., Barco A. Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron 2004, 42:947-959.
22. Stefanko D.P., Barrett R.M., Ly A.R., Reolon G.K., Wood M.A. Modulation of long-term memory for object recognition via HDAC inhibition. Proc Natl Acad Sci U S A 2009, 106:9447-9452.
23. Yeh S.H., Lin C.H., Gean P.W. Acetylation of nuclear factor-kappaB in rat amygdala improves long-term but not short-term retention of fear memory. Mol Pharmacol 2004, 65:1286-1292.
24. Vecsey C.G., Hawk J.D., Lattal K.M., Stein J.M., Fabian S.A., Attner M.A., Cabrera S.M., McDonough C.B., Brindle P.K., Abel T., et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J Neurosci 2007, 27:6128-6140.
25. Fischer A., Sananbenesi F., Wang X., Dobbin M., Tsai L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447:178-182.
26. Dash P.K., Orsi S.A., Moore A.N. Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury. Neuroscience 2009, 163:1-8.
27. Guan J.S., Haggarty S.J., Giacometti E., Dannenberg J.H., Joseph N., Gao J., Nieland T.J., Zhou Y., Wang X., Mazitschek R., et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459:55-60.
28. Chwang W.B., O'Riordan K.J., Levenson J.M., Sweatt J.D. ERK/MAPK regulates hippocampal histone phosphorylation following contextual fear conditioning. Learn Mem 2006, 13:322-328.
29. Koshibu K., Graff J., Beullens M., Heitz F.D., Berchtold D., Russig H., Farinelli M., Bollen M., Mansuy I.M. Protein phosphatase 1 regulates the histone code for long-term memory. J Neurosci 2009, 29:13079-13089.
30. Chwang W.B., Arthur J.S., Schumacher A., Sweatt J.D. The nuclear kinase mitogen- and stress-activated protein kinase 1 regulates hippocampal chromatin remodeling in memory formation. J Neurosci 2007, 27:12732-12742.
31. Miller C.A., Campbell S.L., Sweatt J.D. DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity. Neurobiol Learn Mem 2008, 89:599-603.
32. Miller C.A., Sweatt J.D. Covalent modification of DNA regulates memory formation. Neuron 2007, 53:857-869.
33. Feng J., Zhou Y., Campbell S.L., Le T., Li E., Sweatt J.D., Silva A.J., Fan G Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010, 13:423-430.
34. Bredy T.W., Wu H., Crego C., Zellhoefer J., Sun Y.E., Barad M. Histone modifications around individual BDNF gene promoters in prefrontal cortex are associated with extinction of conditioned fear. Learn Mem 2007, 14:268-276.
35. Lattal K.M., Barrett R.M., Wood M.A. Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. Behav Neurosci 2007, 121:1125-1131.
36. Malvaez M., Sanchis-Segura C., Vo D., Lattal K.M., Wood M.A. Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol Psychiatry 2010, 67:36-43.
37. Amir R.E., Van den Veyver I.B., Wan M., Tran C.Q., Francke U., Zoghbi H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23:185-188.
38. Shahbazian M., Young J., Yuva-Paylor L., Spencer C., Antalffy B., Noebels J., Armstrong D., Paylor R., Zoghbi H. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 2002, 35:243-254.
39. Veldic M., Guidotti A., Maloku E., Davis J.M., Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci U S A 2005, 102:2152-2157.
40. Guidotti A., Ruzicka W., Grayson D.R., Veldic M., Pinna G., Davis J.M., Costa E. S-Adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 2007, 18:57-60.
41. Antun F.T., Burnett G.B., Cooper A.J., Daly R.J., Smythies J.R., Zealley A.K. The effects of l-methionine (without MAOI) in schizophrenia. J Psychiatr Res 1971, 8:63-71.
42. Dong E., Nelson M., Grayson D.R., Costa E., Guidotti A. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc Natl Acad Sci U S A 2008, 105:13614-13619.
43. Levenson J.M. DNA (cytosine-5) methyltransferase inhibitors: a potential therapeutic agent for schizophrenia. Mol Pharmacol 2007, 71:635-637.
44. Renthal W., Maze I., Krishnan V., Covington H.E., Xiao G., Kumar A., Russo S.J., Graham A., Tsankova N., Kippin T.E., et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 2007, 56:517-529.
45. Covington H.E., Maze I., LaPlant Q.C., Vialou V.F., Ohnishi Y.N., Berton O., Fass D.M., Renthal W., Rush A.J., Wu E.Y., et al. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 2009, 29:11451-11460.
46. Scarpa S., Fuso A., D'Anselmi F., Cavallaro R.A. Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease?. FEBS Lett 2003, 541:145-148.
47. Wang S.C., Oelze B., Schumacher A Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS One 2008, 3:e2698.
48. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A 1998, 95:15718-15723.
49. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000, 57:1061-1069.
50. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., Shafa R., Glatt S.J., Nguyen G., Ponte J.F., et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005, 134B:60-66.
51. Poulter M.O., Du L., Weaver I.C., Palkovits M., Faludi G., Merali Z., Szyf M., Anisman H. GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 2008, 64:645-652.
52. Tremolizzo L., Doueiri M.S., Dong E., Grayson D.R., Davis J., Pinna G., Tueting P., Rodriguez-Menendez V., Costa E., Guidotti A. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 2005, 57:500-509.
53. Tsankova N.M., Kumar A., Nestler E.J. Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 2004, 24:5603-5610.
54. Tsankova N.M., Berton O., Renthal W., Kumar A., Neve R.L., Nestler E.J. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006, 9:519-525.
55. Wilkinson M.B., Xiao G., Kumar A., LaPlant Q., Renthal W., Sikder D., Kodadek T.J., Nestler E.J. Imipramine treatment and resiliency exhibit similar chromatin regulation in the mouse nucleus accumbens in depression models. J Neurosci 2009, 29:7820-7832.
56. Keller S., Sarchiapone M., Zarrilli F., Videtic A., Ferraro A., Carli V., Sacchetti S., Lembo F., Angiolillo A., Jovanovic N., et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010, 67:258-267.
57. Dion V., Wilson J.H. Instability and chromatin structure of expanded trinucleotide repeats. Trends Genet 2009, 25:288-297.
58. Coffee B., Zhang F., Ceman S., Warren S.T., Reines D. Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome. Am J Hum Genet 2002, 71:923-932.
59. Coffee B., Zhang F., Warren S.T., Reines D. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat Genet 1999, 22:98-101.
60. Biacsi R., Kumari D., Usdin K. SIRT1 inhibition alleviates gene silencing in Fragile X mental retardation syndrome. PLoS Genet 2008, 4:e1000017.
61. Genc B., Muller-Hartmann H., Zeschnigk M., Deissler H., Schmitz B., Majewski F., von Gontard A., Doerfler W. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals. Nucleic Acids Res 2000, 28:2141-2152.
62. Bell M.V., Hirst M.C., Nakahori Y., MacKinnon R.N., Roche A., Flint T.J., Jacobs P.A., Tommerup N., Tranebjaerg L., Froster-Iskenius U., et al. Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell 1991, 64:861-866.
63. Taylor A.K., Tassone F., Dyer P.N., Hersch S.M., Harris J.B., Greenough W.T., Hagerman R.J. Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am J Med Genet 1999, 84:233-239.
64. Glaser D., Wohrle D., Salat U., Vogel W., Steinbach P. Mitotic behavior of expanded CGG repeats studied on cultured cells: further evidence for methylation-mediated triplet repeat stability in fragile X syndrome. Am J Med Genet 1999, 84:226-228.
65. Kim M.O., Chawla P., Overland R.P., Xia E., Sadri-Vakili G., Cha J.H. Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation. J Neurosci 2008, 28:3947-3957.
66. Wilkinson L.S., Davies W., Isles A.R. Genomic imprinting effects on brain development and function. Nat Rev Neurosci 2007, 8:832-843.
67. Delaval K., Feil R. Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev 2004, 14:188-195.
68. Cook E.H., Courchesne R.Y., Cox N.J., Lord C., Gonen D., Guter S.J., Lincoln A., Nix K., Haas R., Leventhal B.L., et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet 1998, 62:1077-1083.
69. Schroer R.J., Phelan M.C., Michaelis R.C., Crawford E.C., Skinner S.A., Cuccaro M., Simensen R.J., Bishop J., Skinner C., Fender D., et al. Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 1998, 76:327-336.
70. Schanen N.C. Epigenetics of autism spectrum disorders. Hum Mol Genet 2006, 15(Spec No 2):R138-150.
71. Hogart A., Leung K.N., Wang N.J., Wu D.J., Driscoll J., Vallero R.O., Schanen N.C., LaSalle J.M. Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J Med Genet 2009, 46:86-93.
72. Ptak C., Petronis A. Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharmacol Toxicol 2008, 48:257-276.
73. Weaver I.C., Champagne F.A., Brown S.E., Dymov S., Sharma S., Meaney M.J., Szyf M. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 2005, 25:11045-11054.
74. Feinberg A.P., Irizarry R.A. Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and disease. Proc Natl Acad Sci U S A 2010, 107:1757-1764.
75. Gräff J., Mansuy I.M. Epigenetic codes in cognition and behaviour. Behav Brain Res 2008, 192:70-87.